Protein targeting in infectious diseases comes with several challenges. These include the development of drug resistance, as pathogens can rapidly mutate the targeted proteins. Additionally, achieving specificity is difficult; drugs must selectively target pathogen proteins without affecting similar host proteins. Toxicity and off-target effects are other significant concerns that need to be addressed.
